# Genetic Characterization and Biofilm-Forming Capacity of Bacterial Population Isolated from Conjunctival Samples

**Authors:** Adela Voinescu, Silvia-Ioana Musuroi, Monica Licker, Delia Muntean, Florin-George Horhat, Luminita Mirela Baditoiu, Oana Izmendi, Andrei Cosnita, Mihnea Munteanu, Mihai Poenaru-Sava, Valentin Ordodi, Petrinela Ceachir, Tudor Rareș Olariu, Corina Musuroi

PMC · DOI: 10.3390/antibiotics15030300 · Antibiotics · 2026-03-15

## TL;DR

This study analyzed bacteria from conjunctival samples, finding that many are drug-resistant and form biofilms, which may reduce treatment effectiveness.

## Contribution

The study links resistance genes to biofilm formation in conjunctival bacteria, emphasizing biofilm-related antimicrobial resistance in clinical settings.

## Key findings

- Gram-positive cocci, especially Staphylococcus epidermidis, were the most common and multidrug-resistant isolates.
- Biofilm formation was more prevalent in Gram-negative bacteria, though Gram-positive biofilms showed higher antimicrobial tolerance.
- Biofilm-embedded bacteria exhibited increased resistance to amikacin and levofloxacin, particularly in Staphylococcus species.

## Abstract

Background/Objectives: Bacterial conjunctivitis is a common ocular infection requiring prompt treatment, particularly in vulnerable patients, and may influence perioperative outcomes. This study aimed to characterize conjunctival bacterial isolates phenotypically and genotypically, to evaluate their biofilm-forming capacity, and to investigate the relationship between resistance gene carriage, resistance phenotypes, and biofilm-associated antimicrobial resistance (AMR). Methods: A prospective, single-center, cross-sectional study was conducted on bacterial isolates from conjunctival samples of patients examined in an ophthalmology department. Antimicrobial susceptibility testing (AST) was performed to determine the minimum inhibitory concentrations (MICs). Resistance genes were detected by quantitative PCR. Biofilm-forming capacity was assessed using the microtiter plate assay, and biofilm susceptibility to amikacin (AK) and levofloxacin (LEV) was evaluated using a biofilm susceptibility assay. Results: A total of 78 isolates were analyzed; Gram-positive cocci prevailed (GPC, 84.6%), being significantly more frequent than Gram-negative bacilli (GNB, p < 0.001). Among GPC, 65.2% were multidrug-resistant, with Staphylococcus epidermidis emerging as the most frequent species (p < 0.001). Resistance gene carriage was detected in 33.3% of GNB. Strong biofilm formation was observed in 22.7% of GPC versus 58.3% of GNB. It should be noted that the relatively small number of GNB may limit the statistical robustness of comparisons between Gram-positive and Gram-negative groups. A statistically significant association between resistance genes and biofilm capacity was found only in Staphylococcus aureus (p = 0.027). Biofilm-embedded bacteria showed increased antimicrobial tolerance, particularly for AK in S. aureus and for both AK and LEV in S. epidermidis (p < 0.001). Conclusions: The prevalence of multidrug-resistant conjunctival isolates and their biofilm-forming capacity highlights the clinical importance of biofilm-related resistance and support integrating AMR profiling with biofilm assessment to optimize empirical therapy in bacterial conjunctivitis.

## Linked entities

- **Chemicals:** amikacin (PubChem CID 37768), levofloxacin (PubChem CID 149096)
- **Diseases:** bacterial conjunctivitis (MONDO:0006668)
- **Species:** Staphylococcus epidermidis (taxon 1282), Staphylococcus aureus (taxon 1280)

## Full-text entities

- **Genes:** ESBL [NCBI Gene 13906541], ermB [NCBI Gene 9988306], beta-lactamase [NCBI Gene 13915111], beta-Lactamase [NCBI Gene 13913583], BlaZ [NCBI Gene 13874473]
- **Diseases:** eyelid edema (MESH:D004487), MDR (MESH:D018088), ocular inflammation (MESH:D007249), conjunctivitis (MESH:D003231), GN (MESH:D016905), hyperemia (MESH:D006940), infectious (MESH:D003141), burn (MESH:D002056), MRSA (MESH:D013203), ocular surface disease (MESH:D010534), vision loss (MESH:D014786), keratitis (MESH:D007634), ocular and periocular infections (MESH:D015817), Postoperative endophthalmitis (MESH:D009877), XDR (MESH:D054908), immunodeficiency (MESH:D007153), conjunctival infection (MESH:D003229), Bacterial conjunctivitis (MESH:D003234), MR (MESH:D060467), ocular pain (MESH:D058447), GP (MESH:D016908), vernal keratoconjunctivitis (MESH:D003233), cataract (MESH:D002386), coagulase-negative staphylococci (MESH:D064726), glaucoma (MESH:D005901), infection (MESH:D007239), injury to (MESH:D014947)
- **Chemicals:** gentamicin (MESH:D005839), trimethoprim-sulfamethoxazole (MESH:D015662), mecA (MESH:C046756), water (MESH:D014867), LEV (MESH:D064704), Glucose (MESH:D005947), sodium chloride (MESH:D012965), tobramycin (MESH:D014031), penicillin (MESH:D010406), SA (MESH:D000077145), fluoroquinolone (MESH:D024841), Aminoglycoside (MESH:D000617), imipenem (MESH:D015378), ciprofloxacin (MESH:D002939), sulfonamides (MESH:D013449), macrolide (MESH:D018942), cephalosporins (MESH:D002511), oxacillin (MESH:D010068), ceftazidime (MESH:D002442), cefepime (MESH:D000077723), amoxicillin/clavulanate (MESH:D019980), carbapenem (MESH:D015780), agar (MESH:D000362), beta-lactam (MESH:D047090), ampicillin (MESH:D000667), disodium phosphate (MESH:C018279), acetic acid (MESH:D019342), crystal violet (MESH:D005840), polystyrene (MESH:D011137), AK (MESH:D000583), Amikacin A002-1 (-), methicillin (MESH:D008712), meropenem (MESH:D000077731)
- **Species:** Ralstonia insidiosa (species) [taxon 190721], Corynebacterium (genus) [taxon 1716], Serratia marcescens (species) [taxon 615], Enterococcus (genus) [taxon 1350], Streptococcus viridans (species) [taxon 78535], Escherichia coli (E. coli, species) [taxon 562], Klebsiella pneumoniae (species) [taxon 573], Acinetobacter lwoffii (species) [taxon 28090], Staphylococcus lugdunensis (species) [taxon 28035], Aeromonas hydrophila (species) [taxon 644], Ralstonia pickettii (species) [taxon 329], Streptococcus sp. 'group B' (species) [taxon 1319], Pseudomonas aeruginosa (species) [taxon 287], Haemophilus influenzae (species) [taxon 727], Acinetobacter baumannii (species) [taxon 470], Klebsiella planticola (species) [taxon 575], Homo sapiens (human, species) [taxon 9606], Propionibacterium (genus) [taxon 1743], Staphylococcus epidermidis (species) [taxon 1282], Enterobacterales (order) [taxon 91347], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Sphingomonas (genus) [taxon 13687], Staphylococcus haemolyticus (species) [taxon 1283], Staphylococcus aureus (species) [taxon 1280]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13024031/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13024031/full.md

## References

51 references — full list in the complete paper: https://tomesphere.com/paper/PMC13024031/full.md

---
Source: https://tomesphere.com/paper/PMC13024031